Dr. Roberto Gabach: “If it is difficult you plan, if it is impossible you try”
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market. [...]
Sergio Lucero: “Amarin differentiates itself by respecting all the rules and being flexible in dealing”
In transdermal pharmaceutical development, the initial instinct of many business development managers is to default to the largest available CDMO, the assumption being that scale correlates with capability, and that a recognized name reduces risk. [...]
Dr. Francisco Stefano: “The truth is not always what you believe, but what you find”
A review of the evolution of the transdermal market in the voice of Dr. Francisco Stefano, our director. Challenges of science and passion as protagonists. [...]
Alzheimer’s Month
On September 21, World Alzheimer's Day is commemorated, in the context of World Alzheimer's Month. [...]
Opportunities in an evolving market
In a first and superficial approach to the main market indicators, and in line with some publications, we can have feeling of witnessing the twilight of one the most innovative pharmaceutical forms in the industry,.. [...]
World Parkinson’s Day
In 1997, the World Health Organization declared April 11th as World Parkinson's Day, coinciding with the anniversary of the birth of James Parkinson, a British neurologist who, in 1817, discovered what he called 'agitating paralysis' and which we know today as Parkinson's disease. [...]